577 related articles for article (PubMed ID: 25778336)
41. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
Jo JE; Tang EY; Pua BB
Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
[TBL] [Abstract][Full Text] [Related]
42. Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.
Berardi R; Rinaldi S; Santini D; Vincenzi B; Giampieri R; Maccaroni E; Marcucci F; Francoletti M; Onofri A; Lucarelli A; Pierantoni C; Tonini G; Cascinu S
Support Care Cancer; 2015 May; 23(5):1295-302. PubMed ID: 25326782
[TBL] [Abstract][Full Text] [Related]
43. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
Chang YF; Lo AC; Tsai CH; Lee PY; Sun S; Chang TH; Chen CC; Chang YS; Chen JR
Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844
[TBL] [Abstract][Full Text] [Related]
44. Totally implanted venous access devices implanted in the saphenous vein. Relation between the reservoir site and comfort/discomfort of the patients.
Toro A; Mannino M; Cappello G; Celeste S; Cordio S; Di Carlo I
Ann Vasc Surg; 2012 Nov; 26(8):1127.e9-1127.e13. PubMed ID: 22951064
[TBL] [Abstract][Full Text] [Related]
45. Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
Tsuruta S; Goto Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Takamizawa J
Support Care Cancer; 2020 Jun; 28(6):2761-2768. PubMed ID: 31724073
[TBL] [Abstract][Full Text] [Related]
46. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
[TBL] [Abstract][Full Text] [Related]
47. Central line bundle for prevention of central line-associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients.
Devrim İ; Oruç Y; Demirağ B; Kara A; Düzgöl M; Uslu S; Yaşar N; Aydın Köker S; Töret E; Bayram N; Vergin C
J Vasc Access; 2018 Jul; 19(4):358-365. PubMed ID: 29926785
[TBL] [Abstract][Full Text] [Related]
48. Severe Neutropenia at the Time of Implantable Subcutaneous Chest Port Insertion Is Not a Risk Factor for Port Removal at a Tertiary Pediatric Center.
Hoss DR; Bedros AA; Mesipam A; Criddle J; Smith JC
J Vasc Interv Radiol; 2017 Mar; 28(3):398-402. PubMed ID: 28034702
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the position of the central venous catheter tip of implantable venous access devices in the occurrence of postoperative thrombotic and non-thrombotic complications.
Hamri H; Pop CF; Mauriac S; Degreve C; Khaled C; Vouche M; Moreau M; Liberale G
Support Care Cancer; 2024 May; 32(6):355. PubMed ID: 38750256
[TBL] [Abstract][Full Text] [Related]
50. [Complications associated with the placement of subcutaneous central venous access port devices: reasons for removal and complications observed].
Danno K; Ohnishi T; Watanabe A; Ueda M; Yanagawa T; Kim C; Fujita S; Fujita J; Yoshida T; Tono T; Monden T; Imaoka S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2404-6. PubMed ID: 23268092
[TBL] [Abstract][Full Text] [Related]
51. Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?
Covey AM; Toro-Pape FW; Thornton RH; Son C; Erinjeri J; Sofocleous CT; Brody LA; Brown KT; Sepkowitz KA; Getrajdman GI
J Vasc Interv Radiol; 2012 Mar; 23(3):358-62. PubMed ID: 22365295
[TBL] [Abstract][Full Text] [Related]
52. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF
Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372
[TBL] [Abstract][Full Text] [Related]
53. IR Approaches to Difficult Removals of Totally Implanted Venous Access Port Catheters in Children: A Single-Center Experience.
Patel PA; Parra DA; Bath R; Amaral JG; Temple MJ; John PR; Connolly BL
J Vasc Interv Radiol; 2016 Jun; 27(6):876-81. PubMed ID: 27106735
[TBL] [Abstract][Full Text] [Related]
54. Tip Design of Hemodialysis Catheters Influences Thrombotic Events and Replacement Rate.
Petridis C; Nitschke M; Lehne W; Smith E; Goltz JP; Lehnert H; Meier M
Eur J Vasc Endovasc Surg; 2017 Feb; 53(2):262-267. PubMed ID: 27876561
[TBL] [Abstract][Full Text] [Related]
55. Quality-of-life assessment: arm TIVAD versus chest TIVAD.
Burbridge B; Goyal K
J Vasc Access; 2016 Nov; 17(6):527-534. PubMed ID: 27768211
[TBL] [Abstract][Full Text] [Related]
56. Complete catheter disconnection and migration of an implantable venous access device: the disconnected cap sign.
Faraj W; Zaghal A; El-Beyrouthy O; Kutoubi A
Ann Vasc Surg; 2010 Jul; 24(5):692.e11-5. PubMed ID: 20413259
[TBL] [Abstract][Full Text] [Related]
57. Traditional Long-Term Central Venous Catheters Versus Transhepatic Venous Catheters in Infants and Young Children.
Marshall AM; Danford DA; Curzon CL; Anderson V; Delaney JW
Pediatr Crit Care Med; 2017 Oct; 18(10):944-948. PubMed ID: 28746169
[TBL] [Abstract][Full Text] [Related]
58. [Totally implantable central venous access devices in patients with cancer. Experience at a private oncology center].
Cortés-Flores AO; Morgan-Villela G; Juárez-Uzeta EA; Fuentes-Orozco C; Jiménez-Tornero J; González-Ojeda A
Cir Cir; 2012; 80(5):429-34. PubMed ID: 23351446
[TBL] [Abstract][Full Text] [Related]
59. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
[TBL] [Abstract][Full Text] [Related]
60. Risk Factors for Early Port Infections in Adult Oncologic Patients.
Skummer P; Kobayashi K; DeRaddo JS; Blackburn T; Schoeneck M; Patel J; Jawed M
J Vasc Interv Radiol; 2020 Sep; 31(9):1427-1436. PubMed ID: 32792279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
